ScoreWhy is Sichuan Huiyu Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -15.85% and Operating profit at -139.44% over the last 5 years
2
Negative results in Sep 25
- NET SALES(HY) At CNY 502.7 MM has Grown at -17.49%
- NET PROFIT(HY) At CNY 53.87 MM has Grown at -31.32%
- ROCE(HY) Lowest at 1.24%
3
Underperformed the market in the last 1 year
- The stock has generated a return of 6.63% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sichuan Huiyu Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Sichuan Huiyu Pharmaceutical Co., Ltd.
4.71%
0.64
57.50%
China Shanghai Composite
19.02%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-15.85%
EBIT Growth (5y)
-139.44%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.59
Sales to Capital Employed (avg)
0.23
Tax Ratio
8.98%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.75%
ROE (avg)
5.57%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
92
Industry P/E
Price to Book Value
2.02
EV to EBIT
-452.62
EV to EBITDA
96.03
EV to Capital Employed
3.30
EV to Sales
5.54
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.73%
ROE (Latest)
2.20%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
NET PROFIT(HY)
At CNY 81.4 MM has Grown at 130.22%
RAW MATERIAL COST(Y)
Fallen by -0.72% (YoY
PRE-TAX PROFIT(Q)
Highest at CNY 44.2 MM
-11What is not working for the Company
INTEREST(HY)
At CNY 6.45 MM has Grown at 53.2%
OPERATING CASH FLOW(Y)
Lowest at CNY 155.8 MM
ROCE(HY)
Lowest at 0.58%
DEBTORS TURNOVER RATIO(HY)
Lowest at 12.84 times
Here's what is working for Sichuan Huiyu Pharmaceutical Co., Ltd.
Net Profit
At CNY 81.4 MM has Grown at 130.22%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Pre-Tax Profit
Highest at CNY 44.2 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Pre-Tax Profit
At CNY 44.2 MM has Grown at 70.9%
over average net sales of the previous four periods of CNY 25.86 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Raw Material Cost
Fallen by -0.72% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Sichuan Huiyu Pharmaceutical Co., Ltd.
Interest
At CNY 6.45 MM has Grown at 53.2%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Operating Cash Flow
Lowest at CNY 155.8 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Debtors Turnover Ratio
Lowest at 12.84 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
